Cite

HARVARD Citation

    Maruyama, D. et al. (2018). Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trial. Cancer science. 109 (10), pp. 3245-3252. [Online]. 
  
Back to record